On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
All content for The MedTalk Podcast is the property of The MedTalk Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
The FemTech Series: Changing the gynae diagnosis game
The MedTalk Podcast
21 minutes 38 seconds
1 year ago
The FemTech Series: Changing the gynae diagnosis game
Olivia Friett is joined by Stiliyana Minkovska, founder and CEO of Matrix Health and Care, to discuss the current femtech climate and their product which is a digitally enabled, AI-supported pelvic assessment and diagnosis device, designed for self use.
The MedTalk Podcast
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
